Anbio Biotechnology (NNNN) Institutional Ownership

Ownership Summary

A total of 1 institutions have reported a stake in Anbio Biotechnology (NASDAQ:NNNN) as of December 2025, according to recent 13F filings with the SEC.

• The collective stake of institutional investors in Anbio Biotechnology moved to 0.0% in December 2025, a shift down from the 0.1% reported for September 2025.
• Quarterly data indicates a 196.77% shift in institutional share volume, and the annual owner count reflects an unavailable change.
• Among the 1 institutional holders of Anbio Biotechnology, 1 added to their stakes while 0 trimmed their positions and 0 held steady.
• The total number of shares held by institutions in Anbio Biotechnology increased to 2.85K as of December 2025, a net change of up by 1.89K shares quarter on quarter, and down N/A shares year over year.
• UBS Group AG's holding of 2.85K shares as of December 31, 2025 makes it the primary institutional investor in Anbio Biotechnology, owning 0.01% of the stock.
• Among the most significant buyers of Anbio Biotechnology during December 2025 were UBS Group AG (1.89K).
• The top 1 institutional holders of Anbio Biotechnology for the quarter ending December 2025 included UBS Group AG (2.85K).